Access the full text.
Sign up today, get DeepDyve free for 14 days.
(1973)
The antilumor agent Cis-PT (Nh3), GI,: Distribution studies and dose calculations for ImPt and le
R. C. Lange, R. P. Spencer, H. C. Harder (1973)
The antitumor agent Cis‐PT (Nh3)2 Cl2: Distribution studies and dose calculations for 193mPt and 195mPtNucl. Med., 14
U. Schaeppi, I. Heyman, R. Fleischman, H. Rosenkrantz, V. Ilievski, R. Phelan, D. Cooney, R. Davis (1973)
cis-Dichlorodiammineplatinum(II) (NSC-119 875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice.Toxicology and applied pharmacology, 25 2
R. Deconti, B. Toftness, R. Lange, W. Creasey (1973)
Clinical and pharmacological studies with cis-diamminedichloroplatinum (II).Cancer research, 33 6
T. Sherwood, J. Lavender, S. Russell (1974)
Mercury‐Induced Renal Vascular Shut‐Down: Observations in Experimental Acute Renal FailureEuropean Journal of Clinical Investigation, 4
P. H. S. Smith, D. M. Taylor (1974)
Distribution and tetention of the antitumor agent 195mPt‐cis‐Dichlorodiam‐mineplatinum (II) in ManNucl. Med., 15
J. Baddiley, I. Hancock, P. Sherwood (1973)
X-ray Photoelectron Studies of Magnesium Ions bound to the Cell Walls of Gram-positive BacteriaNature, 243
D. Taylor, J. Jones, A. Robins (1973)
Metabolism of platinum ( 14 C)ethylenediamine dichloride in the rat.Biochemical pharmacology, 22 7
B. Leonard, E. Eccleston, D. Jones, P. Todd, A. Walpole (1971)
Antileukaemic and Nephrotoxic Properties of Platinum CompoundsNature, 234
(1974)
Distribution and tetention of the antitumor agent
R. Kociba, S. Sleight (1971)
Acute toxicologic and pathologic effects of cis-diamminedichloroplatinum (NSC-119875) in the male rat.Cancer chemotherapy reports, 55 1
Cis‐Dichlorodiammineplatinum (CPDD) NSC 119875 was given at toxic doses (3 mg/kg) to three groups of dogs. The renal toxicity was avoided with massive prehydration and with mannitol induced diuresis. The bone marrow toxicity was unaltered by either manipulation. The data presented indicate that a better therapeutic index has been achieved by osmotic diuresis with mannitol. Blood levels and urine levels measurements show that the pharmocokinetics of the drug are unaltered, the urinary concentration of drug being low in the first few hours, but with similar urinary drug recovery in all three groups.
Cancer – Wiley
Published: Apr 1, 1977
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.